William (Bill) Amsbaugh is a Partner and Chief Technology Officer (CTO) at Cure Ventures where he heads the firm’s bioinformatics efforts. His career spans 25 years across a variety of technical domains combining his training as an analytical chemist with his expertise in computer science. Bill has been focused on accelerating drug discovery and commercialization utilizing advanced algorithms and architecture across a wide variety of organizations within the biotechnology venture ecosystem.
From 2013 to 2021, Bill has been CTO and co-founder of Precision Health Software. Bill was working with biotech startups leveraging machine learning and AI on the AWS platform to find novel insights within scientific and genetic data. During this period Bill also served as an architect developing a solution for analyzing, annotating somatic variants with The Jackson Laboratory’s Center for Genomic Medicine.
In 2008 to 2013, Bill was working with Third Rock Ventures’ (TRV) portfolio company, Constellation Pharmaceuticals building fully automated HTS platforms for a collaboration with Roche/Genentech. He also advised other portfolio companies on IT/Informatics strategies consulting for other TRV companies such as Intellia Therapeutics, Editas Medicine, Sage Therapeutics, in areas of informatics, IT design, and software vendor selection. He previously managed informatics at Gene Logic annotating transcriptional databases and aggregating data to facilitate the mission of drug repositioning and selection.
Bill received a BS in Chemistry from Western New England University and his MS in Computer Science from Boston University. Mr. Amsbaugh received additional certifications in Software Architecture from Carnegie Mellon’s Software Engineering Institute as well as certification in Digital Forensics from Boston University.